Los anticuerpos monoclonales (mAbs) se han utilizado para tratar muchas enfermedades, incluida la COVID-19 y virus respiratorio sincitial (VRS).
Esta hoja informativa del NFID en español proporciona información sobre los anticuerpos monoclonales (mAbs) y las diferencias entre las vacunas y los mAbs.
View in English
Related Resources
Sonya’s Story (COVID-19)
A daughter prays that her mother’s death helps others understand the dangers of COVID-19
Contagious Chronicles: Don’t Be A Dreaded Spreader
In this episode, NFID experts offer insights on updated recommendations from the Centers for Disease Control and Prevention (CDC) to help prevent the spread of respiratory viruses, including COVID-19, influenza (flu), and respiratory syncytial virus (RSV)
Contagious Chronicles: Updates on COVID-19, RSV, and More
In the inaugural episode, NFID experts discuss new COVID-19 vaccine recommendations for older adults and other updates from the February 2024 meeting of the Advisory Committee on Immunization Practices (ACIP) …